Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral chloral hydrate versus intranasal dexmedetomidine for pediatric EEG sedation
IRCT20180520039739N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of chloral hydrate and dexmedetomidine (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Ramsay score scale. Started Apr 2018; status: completed.
02
Drugs
chloral hydratedexmedetomidine
Beyond the preview
Go deeper on IRCT20180520039739N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180520039739N3.